Smoking and atherosclerotic cardiovascular disease: part IV: genetic markers associated with smoking.
Genes influence smoking behavior, affect the metabolism of nicotine and specific chemicals produced during combustion, and enhance (or diminish) pathomechanistic pathways associated with the atherogenic potential of smoking, including oxidative stress, its inflammatory burden or procoagulant potential. Genome-wide association studies have revolutionized the search for new functional genetic markers with ever increasing marker density and the precision in identifying new genetic loci without the need for prior knowledge of functional pathways. Nevertheless, the statistical challenge remains to identify the few true positives, the need for replication of findings and the tedious work of identifying functional genetic variants and their mode of action. Genetic variation within a gene or in areas of the genetic code that control the expression of such a gene is far from being understood. Major advances include the detection of large-scale copy-number variants in the human genome and the demonstration of the decisive role of 'miRNA' in controlling gene expression. The role of the genomic methylation pattern in controlling the transcription of the underlying genetic sequence and its role in interacting with environmental influences have yet to be explored in depth. Although candidate genes and their genetic variants have been associated with atherosclerosis and cigarette smoking, a major breakthrough has still to be made.
Winkelmann
Bernhard R
BR
ClinPhenomics GmbH, 67125 Dannstadt, Germany.
von Holt
Klaus
K
Unverdorben
Martin
M
D050197:Atherosclerosis / Q000378:metabolism / Q000503:physiopathology*; D056915:DNA Copy Number Variations; D005819:Genetic Markers; D014644:Genetic Variation; D006487:Hemostasis; D006801:Humans; D007249:Inflammation; D018384:Oxidative Stress; D020641:Polymorphism, Single Nucleotide; D012907:Smoking / Q000009:adverse effects / Q000235:genetics*
D005819:Genetic Markers